Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00759174 · ClinicalTrials.gov registry record
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
A clinical trial, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- 673
- Enrollment target
NCT00759174: Completed study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
NCT00759174 is a clinical trial that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 673 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00759174 has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- 673 participants
- Enrollment target
Study Summary
The objective of this non-interventional study is to examine whether use of Phosphodiesterase Inhibitors (PDE5s), including use of sildenafil, vardenafil, or tadalafil, triggers the onset of acute NAION.
Primary Outcome
Adjudication committee classified participants as Definite, Possible, or Non-NAION cases, or insufficient information available or unable to adjudicate. Case window: 1 day preceding symptom onset day; 29 control windows: 29 days preceding case window. A case or control window was considered exposed if: sildenafil/vardenafil was used on that day and/or previous day; tadalafil was used on that day and/or any of previous 4 days. In this analysis, each participant contributed exposure information fo
Interventions
- DRUG No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 673 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-10 |
What the finished NCT00759174 record still lists
NCT00759174 is an observational study that tracks outcomes without assigning an intervention. The registered 673 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00759174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00759174 about?
NCT00759174 is a clinical study titled "A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION". The objective of this non-interventional study is to examine whether use of Phosphodiesterase Inhibitors (PDE5s), including use of sildenafil, vardenafil, or tadalafil, triggers the onset of acute NAION.
What is the current status of trial NCT00759174?
This trial is currently completed. The enrollment target is 673 participants. The study started on 2008-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00759174?
The interventions under investigation include: No intervention (DRUG).
Who is sponsoring clinical trial NCT00759174?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06335381 · 674 participants · NA
MOMs Chat and Care Study
- NCT06757634 · 674 participants · Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia